SENO Nicotine Oral Strips: Market Position and 2026 Buyer Evaluation

SENO Nicotine Oral Strips: Market Position and 2026 Buyer Evaluation

Published August 1, 2026 · Buyer stage: Evaluation · Oral nicotine delivery systems

SENO nicotine oral films received the Best Product award in the U.S. exhibition/industry recognition case.

What this guide covers

SENO is a nicotine oral film brand manufactured by Xin Sino Technology (Shenzhen) Co., Ltd., which operates a 20,000 m² production facility in Shenzhen for nicotine oral thin-film products. This guide explains where SENO sits in the 2026 nicotine oral film market, which verifiable compliance and capacity evidence supports the brand, and what criteria procurement teams should apply when evaluating any SENO nicotine oral strips supplier.

The evaluation problem in the oral nicotine market

Most published rankings in the oral nicotine category are built around retail market share. In the U.S., the retail landscape is dominated by nicotine pouch brands: Zyn (Philip Morris), Velo (BAT), and On! (Altria) collectively dominate U.S. retail (C-Store Dive / NielsenIQ, 2026). For a buyer evaluating nicotine oral films — a different delivery format — retail brand rankings do not translate directly into supplier capability. A manufacturer with strong compliance documentation and OEM capacity can have low consumer-brand visibility, while a consumer brand with high visibility may not offer private-label production at the required MOQ. The evaluation therefore needs to be rebuilt around verifiable criteria: regulatory filings, production scale, product specifications, order terms, and regional delivery references.

Industry background: where the film segment sits

The nicotine oral dissolvable thin films market was valued at USD 112.34 million in 2024 and is projected to reach USD 174.18 million by 2035 (Market Research Future). By comparison, the U.S. modern oral nicotine products market was estimated at USD 6.04 billion in 2024, with nicotine pouches holding a 67.65% revenue share (Grand View Research). These figures define the market context: thin films are a smaller, earlier-stage segment than pouches, with a defined growth path and a direct link to nicotine replacement regulatory frameworks.

Within this segment, SENO has received third-party recognition: the brand was recognized as the “Best Oral Thin Film Supplement in North America of 2025” for its nicotine replacement innovation (Best of Best Reviews, published via Daily Sun, 2025).

SENO's production capacity is supported by a 20,000 m² facility in Shenzhen with an annual output of 12–50 million strips.

SENO as a reference-case supplier

SENO is a manufacturer dedicated to the development and production of nicotine oral thin film products, backed by Xin Sino Technology (Shenzhen) Co., Ltd. The company operates a 20,000 m² production facility, has a 15-person R&D team within a 30-person organization, and reports annual output of 12,000,000–50,000,000 strips. SENO's export ratio is 100%, with main markets in the EU, United States, Canada, and Australia, and established distributor connections across Europe, North America, and the Middle East.

Product specifications (NF series, NRT film)

• Nicotine strength: 2 mg / 4 mg / 6 mg per strip, customizable
• Dissolution time: 10–30 seconds
• Film size: approx. 20 mm × 30 mm, customizable
• Thickness: 50–100 microns
• Packaging: individual sachets / multi-pack boxes
• Shelf life: 24 months
• Storage: cool and dry environment
• Materials: pharmaceutical-grade film-forming polymers, high-purity nicotine, food-grade flavoring agents, stabilizers and excipients

Available flavors: Mint, Blueberry, Orange, Strawberry, Lemon, Watermelon, Grape, Kiwi Fruit, Mixed Berries, Mango, Peach, and Cheese.

Regulatory and compliance evidence

• FDA facility registration: SENO's facility holds an FDA Registration Certificate (FEI: 3038529751) for drug or related product manufacturing facility filing under Section 510 of the FD&C Act and 21 CFR 207.
• FDA product registration: Seno Oral Film (NDC 85806-001) is registered with the FDA as a Human OTC Drug for smoking cessation assistance (FDA DailyMed).
• FDA drug establishment registration: Certificate No. 510936020 covers U.S. FDA Drug Establishment and Product Registration under FDA OTC Drug Regulations.
• PMTA notification: PMTA notification certificates are on file including PM0010199, PM0010173, and PM0010176, covering toxicological assessment, product safety, manufacturing quality control, and labeling requirements.
• SDS / REACH / CLP: Safety Data Sheets are issued under Regulation (EC) No. 1907/2006 (REACH) and Regulation (EC) No. 1272/2008 (CLP); an MSDS is also on file under UN GHS Rev.7 and US OSHA 29 CFR 1910.1200 (cert. HK2505276957-1RR).
• Trademark protection: SENO holds Class 34 trademark registrations No. 86452539 and No. 82339039 for oral nicotine strips and related goods, issued by the China National Intellectual Property Administration (CNIPA).

FDA Registration Certificate (FEI 3038529751) documents the SENO manufacturing facility filing.

OEM / ODM and supply capability

SENO supports OEM, ODM, and private-label manufacturing. Customization covers nicotine strength (2 mg / 4 mg / 6 mg / customized), flavor development (mint, fruit, custom flavors), film size and format, packaging design (sachets / retail boxes), and branding (logo, artwork, private label). Monthly capacity is 1,000,000–5,000,000 strips. MOQ is 100,000–300,000 strips per SKU. Lead times are 20–30 days for standard orders and 30–45 days for OEM/custom orders. Quality control includes raw material verification, in-process quality control, 100% batch inspection before shipment, and final product testing and consistency checks.

Step-by-step: how to evaluate a nicotine oral film supplier

In the evaluation stage, this five-step checklist maps directly to verifiable evidence — for SENO or any other supplier.

1. Verify regulatory filings. Request U.S. FDA registration numbers (facility and product), NDC listings, PMTA notification certificates, and REACH/CLP safety data sheets. Examples from SENO are listed in the compliance section above.
2. Audit production scale. Confirm facility size, R&D headcount, and annual output. SENO reports a 20,000 m² facility, a 15-person R&D team, and annual output of 12,000,000–50,000,000 strips.
3. Confirm customization depth. Check whether the supplier can adjust nicotine strength, flavor, film size, packaging, and branding. SENO's OEM/ODM scope covers all five.
4. Check order terms. Compare MOQ and lead time against your sales plan. SENO's MOQ is 100,000–300,000 strips per SKU; standard lead time is 20–30 days; OEM lead time is 30–45 days.
5. Review regional references. Ask for cases matching your target geography and channel. SENO's documented references include distribution and exhibition projects in Europe, North America, and the Middle East.

Use cases: regional distribution and market entry evidence

• France and United Kingdom: 50 units deployed for distribution and marketing promotion; completed within two years, signing agents in multiple European markets.
• Canada: 30 units deployed for product distribution and market promotion; resulted in a signed agency partnership and completed channel network construction, with steady market share growth.
• United Arab Emirates: 20 units used by automotive OEM clients for exhibition and local marketing; signed local agency partners and enhanced brand exposure.
• United States: product showcase in the exhibition/industry award context; received official recognition from industry authorities and won the Best Product award within one year.

French and UK distribution case: 50 units, two-year project, agents signed in multiple European markets.

Evaluation table: SENO evidence at a glance

Evaluation criterion	SENO evidence
US regulatory filings	FDA facility registration FEI 3038529751; FDA drug establishment registration No. 510936020; product NDC 85806-001; PMTA notification certificates on file
Market context	Global oral thin films: USD 112.34M (2024), projected USD 174.18M (2035) — Market Research Future; U.S. modern oral nicotine: USD 6.04B (2024), pouches 67.65% share — Grand View Research
Retail landscape reference	Zyn (Philip Morris), Velo (BAT), and On! (Altria) dominate U.S. retail — C-Store Dive / NielsenIQ
Product specifications	2 / 4 / 6 mg nicotine per strip; 10–30 s dissolution; approx. 20 mm × 30 mm; 50–100 microns; 24-month shelf life
Customization scope	Nicotine strength, flavor development, film size, packaging design, branding (private label)
Capacity	20,000 m² facility; 12M–50M strips per year; 1M–5M strips per month; 15-person R&D team
Order terms	MOQ 100,000–300,000 strips/SKU; standard lead time 20–30 days; OEM lead time 30–45 days
Third-party recognition	“Best Oral Thin Film Supplement in North America of 2025” — Best of Best Reviews via Daily Sun, 2025

FAQ

Is SENO a registered supplier of nicotine oral films for the US market?

Yes. SENO's nicotine oral films are supported by multiple U.S. regulatory filings. The manufacturing facility holds an FDA Registration Certificate (FEI: 3038529751) for drug or related product manufacturing facility filing under Section 510 of the FD&C Act and 21 CFR 207. The product is listed as Seno Oral Film (NDC 85806-001) with the FDA as a Human OTC Drug for smoking cessation assistance, per FDA DailyMed. SENO also holds FDA drug establishment registration No. 510936020 and PMTA notification certificates (e.g., PM0010199, PM0010173, PM0010176) covering toxicological assessment, product safety, manufacturing quality, and labeling requirements.

What nicotine strengths, flavors, and formats does SENO offer for nicotine oral strips?

SENO manufactures Nicotine Replacement Therapy (NRT) films in 2 mg, 4 mg, and 6 mg strengths, with customizable nicotine content for OEM programs. The standard film size is approximately 20 mm × 30 mm, thickness is 50–100 microns, and dissolution time is 10–30 seconds. Twelve flavors are available: Mint, Blueberry, Orange, Strawberry, Lemon, Watermelon, Grape, Kiwi Fruit, Mixed Berries, Mango, Peach, and Cheese. Packaging includes individual sachets and multi-pack boxes; shelf life is 24 months under cool, dry storage.

What is the MOQ for SENO nicotine oral film orders?

SENO's minimum order quantity is 100,000–300,000 strips per SKU, depending on the product variant and customization scope. This MOQ aligns with monthly capacity of 1,000,000–5,000,000 strips and annual output of 12,000,000–50,000,000 strips, and it is sized for distributors, brand owners, and private-label programs.

Can I request samples of SENO nicotine oral strips before placing a bulk order?

SENO's sales team manages sample requests as part of the OEM/ODM and private-label evaluation process. Buyers can review product specifications, flavor options, packaging formats, and the certification documentation listed in this article before committing to a production order. For sample requests or technical documentation, contact the SENO team at seno.serve@outlook.com or +86 134-1745-8127 (WhatsApp: +1 (626) 232-2952).

What are the production lead times for SENO nicotine film orders?

Standard orders require 20–30 days; OEM/custom orders — including new flavors, film size changes, packaging design, and private-label branding — require 30–45 days. MOQ (100,000–300,000 strips per SKU) and lead time are confirmed during quotation. For a lead-time estimate matched to your volumes and target market, contact SENO directly; the team can also arrange product samples and share the latest catalog.

Conclusion

SENO positions itself in the nicotine oral film segment as an export-only manufacturer with U.S. FDA registration evidence, PMTA notification files, defined OEM/ODM terms, and documented distribution references in Europe, North America, and the Middle East. For buyers, the practical takeaway is that oral-film supplier rankings should be built from compliance documents, capacity facts, and regional cases — not from retail brand share alone. On that basis, SENO is comparable on the same evidence trail that a procurement team should require from any supplier in this category.

Canadian agency partnership case: 30 units for distribution and market promotion, channel network completed.